{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:28:11Z","timestamp":1791833291866,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117349","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T23:41:17Z","timestamp":1758152477000},"page":"117349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"P2","title":["Precision vaccine design targeting the prefusion state of viral glycoproteins: advances in structural vaccinology"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0916-7926","authenticated-orcid":false,"given":"Reetesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somnath","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitri","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117349_b0005","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","article-title":"Viral membrane fusion","author":"Harrison","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.bcp.2025.117349_b0010","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117349_b0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/v13071320","article-title":"Targeting viral surface proteins through structure-based design","volume":"13","author":"Narkhede","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2025.117349_b0020","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0025","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/s41467-024-46295-8","article-title":"Engineered dityrosine-bonding of the RSV prefusion F protein imparts stability and potency advantages","volume":"15","author":"Gidwani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117349_b0030","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/v14081816","article-title":"Stabilisation of viral membrane fusion proteins in prefusion conformation by structure-based design for structure determination and vaccine development","volume":"14","author":"Ebel","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2025.117349_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5575","article-title":"Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM","volume":"7","author":"Xu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2025.117349_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117349_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2022.1009451","article-title":"SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility","volume":"4","author":"Val\u00e9rio","year":"2022","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.bcp.2025.117349_b0050","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1021\/acs.jcim.1c00560","article-title":"Key interacting residues between RBD of SARS-CoV-2 and ACE2 receptor: combination of molecular dynamics simulation and density functional calculation","volume":"61","author":"Jawad","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bcp.2025.117349_b0055","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3390\/v15122405","article-title":"Dramatic differences between the structural susceptibility of the S1 Pre- and S2 postfusion states of the SARS-CoV-2 spike protein to external electric fields revealed by molecular dynamics simulations","volume":"15","author":"Lipskij","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2025.117349_b0060","unstructured":"SARS-CoV-2 spike engagement of ACE2 primes S2\u2032 site cleavage and fusion initiation | PNAS, (n.d.). https:\/\/www.pnas.org\/doi\/full\/10.1073\/pnas.2111199119?utm_source=chatgpt.com (accessed June 2, 2025)."},{"key":"10.1016\/j.bcp.2025.117349_b0065","article-title":"Spike protein mediated membrane fusion during SARS\u2010CoV\u20102 infection","volume":"95","author":"Li","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1288686","article-title":"Structural understanding of SARS-CoV-2 virus entry to host cells","volume":"10","author":"Le","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bcp.2025.117349_b0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404250121","article-title":"Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation","volume":"121","author":"Sponholtz","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2025.117349_b0080","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1073\/pnas.1523303113","article-title":"Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form","volume":"113","author":"Wong","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2025.117349_b0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/v15020558","article-title":"SARS-CoV-2 S Glycoprotein Stabilization Strategies","volume":"15","author":"Pedenko","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2025.117349_b0090","doi-asserted-by":"crossref","first-page":"12265","DOI":"10.1073\/pnas.1811980115","article-title":"Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4","volume":"115","author":"Stewart-Jones","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117349_b0095","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3389\/fimmu.2020.00842","article-title":"Structure-based design of nipah virus vaccines: a generalizable approach to paramyxovirus immunogen development","volume":"11","author":"Loomis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117349_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade6422","article-title":"Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine","volume":"15","author":"Che","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117349_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.066","article-title":"Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster","volume":"42","author":"Jitender","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.bcp.2025.117349_b0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.procbio.2024.08.022","article-title":"Scalable bioprocess for high-yield production of SARS-CoV-2 trimeric spike protein-based immunogen (IMT-CVAX) using suspension CHO cells","volume":"147","author":"Singh","year":"2024","journal-title":"Process Biochem."},{"key":"10.1016\/j.bcp.2025.117349_b0115","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/v15040856","article-title":"Understanding mutations in human SARS-CoV-2 spike glycoprotein: a systematic review & meta-analysis","volume":"15","author":"Kumar","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2025.117349_b0120","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102209","article-title":"Principles and practical applications of structure-based vaccine design","volume":"77","author":"Byrne","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bcp.2025.117349_b0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.chom.2021.02.002","article-title":"Virus vaccines: proteins prefer prolines","volume":"29","author":"Sanders","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bcp.2025.117349_b0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-4690-11-26","article-title":"Structural and biochemical insights into the V\/I505T mutation found in the EIAV gp45 vaccine strain","volume":"11","author":"Du","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.bcp.2025.117349_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1406929","article-title":"Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins","volume":"15","author":"Gonzalez","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117349_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2020.100478","article-title":"Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach","volume":"21","author":"Sarkar","year":"2020","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.bcp.2025.117349_b0150","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1039\/D1SC01928G","article-title":"Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates","volume":"13","author":"Carboni","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bcp.2025.117349_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1406929","article-title":"Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins","volume":"15","author":"Gonzalez","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117349_b0160","article-title":"Precise modification of the surface charge of antigen enhances vaccine immunogenicity","volume":"4","author":"Zai","year":"2023","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.bcp.2025.117349_b0165","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2025.117349_b0170","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41467-024-45480-z","article-title":"A general computational design strategy for stabilizing viral class I fusion proteins","volume":"15","author":"Gonzalez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117349_b0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.bcp.2025.117349_b0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.sbi.2018.06.002","article-title":"Structure-based immunogen design\u2014leading the way to the new age of precision vaccines","volume":"51","author":"Sesterhenn","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bcp.2025.117349_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1126034","article-title":"Glycan masking in vaccine design: Targets, immunogens and applications","volume":"14","author":"Martina","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117349_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010981","article-title":"Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core","volume":"19","author":"Poumbourios","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2025.117349_b0195","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jmb.2011.02.053","article-title":"Contribution of hydrophobic interactions to protein stability","volume":"408","author":"Pace","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117349_b0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117349_b0210","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01372-23","article-title":"Prefusion stabilization of the Hendra and Langya virus F proteins","volume":"98","author":"Byrne","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0215","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1038\/ncomms9143","article-title":"A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism","volume":"6","author":"Krarup","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117349_b0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nature04322","article-title":"Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation","volume":"439","author":"Yin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117349_b0225","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005322","article-title":"Crystal structure of the pre-fusion nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly","volume":"11","author":"Xu","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2025.117349_b0235","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41467-022-28931-3","article-title":"Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins","volume":"13","author":"Hsieh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117349_b0240","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0245","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117349_b0250","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2024.12.021","article-title":"Structural and functional analysis of the Nipah virus polymerase complex","volume":"188","author":"Hu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117349_b0255","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","article-title":"Viral membrane fusion","volume":"479\u2013480","author":"Harrison","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.bcp.2025.117349_b0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2014.01.005","article-title":"Activation of paramyxovirus membrane fusion and virus entry","volume":"5","author":"Jardetzky","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0265","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.1219021","article-title":"The Protein-Folding Problem, 50 Years on","volume":"338","author":"Dill","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0270","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution","volume":"6","author":"Zahradn\u00edk","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bcp.2025.117349_b0275","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1126\/science.abo7896","article-title":"Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution","volume":"377","author":"Starr","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0280","doi-asserted-by":"crossref","first-page":"11437","DOI":"10.1128\/JVI.00779-08","article-title":"The measles virus fusion protein transmembrane region modulates availability of an active glycoprotein complex and fusion efficiency","volume":"82","author":"M\u00fchlebach","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0285","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117349_b0290","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bcp.2025.117349_b0295","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41577-020-00428-4","article-title":"The global response to the COVID-19 pandemic: how have immunology societies contributed?","volume":"20","author":"Osier","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2025.117349_b0300","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nsmb.3267","article-title":"Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine","volume":"23","author":"Joyce","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117349_b0305","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"the VRC 317 Study Team, a proof of concept for structure-based vaccine design targeting RSV in humans","volume":"365","author":"Crank","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0310","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.128","article-title":"Structures of ebola virus GP and sGP in complex with therapeutic antibodies","volume":"1","author":"Pallesen","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bcp.2025.117349_b0320","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nsmb.2250","article-title":"Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site","volume":"19","author":"Wen","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117349_b0325","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117349_b0330","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117349_b0335","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117349_b0340","series-title":"Advances in Virus Research","first-page":"93","article-title":"Chapter four - Structural insights into coronavirus entry","author":"Tortorici","year":"2019"},{"key":"10.1016\/j.bcp.2025.117349_b0345","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nsmb.3267","article-title":"Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV","volume":"23","author":"Joyce","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117349_b0350","doi-asserted-by":"crossref","unstructured":"M. Sasaki, S. Toba, Y. Itakura, H.M. Chambaro, M. Kishimoto, K. Tabata, K. Intaruck, K. Uemura, T. Sanaki, A. Sato, W.W. Hall, Y. Orba, H. Sawa, SARS-CoV-2 Bearing a Mutation at the S1\/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity, mBio 12 (n.d.) e01415-21. doi:10.1128\/mBio.01415-21.","DOI":"10.1128\/mBio.01415-21"},{"key":"10.1016\/j.bcp.2025.117349_b0355","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00831-20","article-title":"Comparison of severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts","volume":"94","author":"Zhai","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0360","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.3390\/ijms22147425","article-title":"Structural evaluation of the spike glycoprotein variants on SARS-CoV-2 transmission and immune evasion","volume":"22","author":"Salleh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117349_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241168","article-title":"Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of \u201cup\u201d versus \u201cdown\u201d protomer states","volume":"15","author":"Peters","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117349_b0370","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/v14030640","article-title":"Mutations and evolution of the SARS-CoV-2 spike protein","volume":"14","author":"Magazine","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2025.117349_b0375","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1096\/fj.06-7052hyp","article-title":"The relevance of salt bridges for the stability of the influenza virus hemagglutinin","volume":"21","author":"Rachakonda","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2025.117349_b0380","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1128\/JVI.01060-08","article-title":"Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition","volume":"82","author":"He","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0385","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fmicb.2014.00165","article-title":"Protective role of salt in catalysis and maintaining structure of halophilic proteins against denaturation","volume":"5","author":"Sinha","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2025.117349_b0390","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-5793(90)80839-B","article-title":"The influence of proline residues on \u03b1-helical structure","volume":"277","author":"Woolfson","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2025.117349_b0395","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2025.117349_b0400","doi-asserted-by":"crossref","first-page":"22725","DOI":"10.1074\/jbc.M200089200","article-title":"Structural characterizations of fusion peptide analogs of influenza virus hemagglutinin. Implication of the necessity of a helix-hinge-helix motif in fusion activity","volume":"277","author":"Hsu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117349_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1445115","article-title":"Circulation of new lineages of RSV-A and RSV-B in Kuwait shows high diversity in the N- and O-linked glycosylation sites in the G protein between 2020 and 2022","volume":"14","author":"Madi","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bcp.2025.117349_b0410","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1093\/emboj\/20.16.4432","article-title":"Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics","volume":"20","author":"Cross","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117349_b0415","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.adp2362","article-title":"Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation","volume":"385","author":"Liang","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117349_b0425","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1128\/JVI.00797-10","article-title":"Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus","volume":"84","author":"Sun","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0430","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/v16060984","article-title":"Host cell proteases involved in human respiratory viral infections and their inhibitors: a review","volume":"16","author":"Lubinski","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2025.117349_b0435","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","article-title":"Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis","volume":"591","author":"Johnson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117349_b0440","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/vaccines8040607","article-title":"Flexible RSV prefusogenic fusion glycoprotein exposes multiple neutralizing epitopes that may collectively contribute to protective immunity","volume":"8","author":"Patel","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bcp.2025.117349_b0445","doi-asserted-by":"crossref","first-page":"31642","DOI":"10.1074\/jbc.M102633200","article-title":"Proteolytic activation of respiratory syncytial virus fusion protein: cleavage at two furin consensus sequences","volume":"276","author":"Zimmer","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117349_b0450","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pro.2860","article-title":"Clusters of isoleucine, leucine, and valine side chains define cores of stability in high\u2010energy states of globular proteins: Sequence determinants of structure and stability","volume":"25","author":"Kathuria","year":"2016","journal-title":"Protein Sci."},{"key":"10.1016\/j.bcp.2025.117349_b0455","doi-asserted-by":"crossref","unstructured":"C.-L. Hsieh, J.A. Goldsmith, J.M. Schaub, A.M. DiVenere, H.-C. Kuo, K. Javanmardi, K.C. Le, D. Wrapp, A.G.-W. Lee, Y. Liu, C.-W. Chou, P.O. Byrne, C.K. Hjorth, N.V. Johnson, J. Ludes-Meyers, A.W. Nguyen, J. Park, N. Wang, D. Amengor, J.A. Maynard, I.J. Finkelstein, J.S. McLellan, Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes, bioRxiv (2020) 2020.05.30.125484. doi:10.1101\/2020.05.30.125484.","DOI":"10.1101\/2020.05.30.125484"},{"key":"10.1016\/j.bcp.2025.117349_b0460","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/092986609788681715","article-title":"Composition and functions of the influenza fusion peptide","volume":"16","author":"Cross","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bcp.2025.117349_b0465","doi-asserted-by":"crossref","first-page":"30514","DOI":"10.1074\/jbc.M403760200","article-title":"Structural Basis for Coronavirus-mediated Membrane Fusion: crystal structure of mouse hepatitis virus spike protein fusion core","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117349_b0470","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.theochem.2004.02.018","article-title":"Structural similarity between HIV-1 gp41 and SARS-CoV S2 proteins suggests an analogous membrane fusion mechanism","volume":"677","author":"Wu Zhang","year":"2004","journal-title":"Theochem"},{"key":"10.1016\/j.bcp.2025.117349_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198845","article-title":"Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases","volume":"318","author":"Shokeen","year":"2022","journal-title":"Virus Res."},{"key":"10.1016\/j.bcp.2025.117349_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108254","article-title":"Furin inhibitors block SARS-CoV-2 spike protein cleavage to suppress virus production and cytopathic effects","volume":"33","author":"Cheng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.117349_b0485","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/jgid.jgid_178_22","article-title":"Distribution and functional analyses of mutations in spike protein and phylogenic diversity of SARS-CoV-2 variants emerged during the year 2021 in India","volume":"15","author":"Gopalan","year":"2023","journal-title":"J. Glob. Infect."},{"key":"10.1016\/j.bcp.2025.117349_b0490","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01205-21","article-title":"Mechanism of cross-resistance to fusion inhibitors conferred by the K394R mutation in respiratory syncytial virus fusion protein","volume":"95","author":"Tang","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117349_b0495","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1371\/journal.pcbi.0030011","article-title":"Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope","volume":"3","author":"Poon","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bcp.2025.117349_b0500","article-title":"The importance of glycans of viral and host proteins in enveloped virus infection","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117349_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.795741","article-title":"Glycan masking of epitopes in the NTD and RBD of the spike protein elicits broadly neutralizing antibodies against SARS-CoV-2 Variants","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:12:41Z","timestamp":1761455561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":100,"alternative-id":["S0006295225006148"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117349","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision vaccine design targeting the prefusion state of viral glycoproteins: advances in structural vaccinology","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117349"}}